{
    "organizations": [],
    "uuid": "5da63edc041a565292988bb4e06a94901ee02807",
    "author": "",
    "url": "https://www.reuters.com/article/brief-intercept-pharma-says-sumitomo-dai/brief-intercept-pharma-says-sumitomo-dainippon-pharma-enters-into-amendment-to-certain-license-agreement-idUSFWN1Q61GD",
    "ord_in_thread": 0,
    "title": "BRIEF-Intercept Pharma Says Sumitomo Dainippon Pharma Enters Into Amendment To Certain License Agreement",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "Feb 16 (Reuters) - Sumitomo Dainippon Pharma Co Ltd :\n* INTERCEPT PHARMA SAYS ON FEB 13, CO, SUMITOMO DAINIPPON PHARMA ENTERED INTO AMENDMENT TO CERTAIN LICENSE AGREEMENT DATED AS OF MARCH 29, 2011\n* INTERCEPT PHARMACEUTICALS INC - UNDER AMENDMENT, SUMITOMO DAINIPPON AGREED TO RETURN RIGHTS TO DEVELOP AND COMMERCIALIZE OCA IN JAPAN AND KOREA\n* INTERCEPT PHARMA - AGREED TO FOREGO ANY FURTHER MILESTONE OR ROYALTY PAYMENTS RELATING TO DEVELOPMENT AND COMMERCIALIZATION OF OCA IN JAPAN AND KOREA\n* INTERCEPT PHARMA - SUMITOMO DAINIPPON WAIVED RIGHTS TO COUNTRY OPTION, PARTIES ADJUSTED CERTAIN MILESTONE PAYMENT OBLIGATIONS REGARDING OCA\n* INTERCEPT PHARMA - SUMITOMO MAY CHOOSE TO PAY CO MILESTONE PAYMENT OR TERMINATE DEAL IF CERTAIN CLINICAL MILESTONES IN CHINA NOT MET BY DEC 31, 2020 Source text: ( bit.ly/2octk8w ) Further company coverage:\n ",
    "published": "2018-02-17T00:33:00.000+02:00",
    "crawled": "2018-02-17T00:44:38.012+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "feb",
        "reuters",
        "sumitomo",
        "dainippon",
        "pharma",
        "co",
        "ltd",
        "intercept",
        "pharma",
        "say",
        "feb",
        "co",
        "sumitomo",
        "dainippon",
        "pharma",
        "entered",
        "amendment",
        "certain",
        "license",
        "agreement",
        "dated",
        "march",
        "intercept",
        "pharmaceutical",
        "inc",
        "amendment",
        "sumitomo",
        "dainippon",
        "agreed",
        "return",
        "right",
        "develop",
        "commercialize",
        "oca",
        "japan",
        "korea",
        "intercept",
        "pharma",
        "agreed",
        "forego",
        "milestone",
        "royalty",
        "payment",
        "relating",
        "development",
        "commercialization",
        "oca",
        "japan",
        "korea",
        "intercept",
        "pharma",
        "sumitomo",
        "dainippon",
        "waived",
        "right",
        "country",
        "option",
        "party",
        "adjusted",
        "certain",
        "milestone",
        "payment",
        "obligation",
        "regarding",
        "oca",
        "intercept",
        "pharma",
        "sumitomo",
        "may",
        "choose",
        "pay",
        "co",
        "milestone",
        "payment",
        "terminate",
        "deal",
        "certain",
        "clinical",
        "milestone",
        "china",
        "met",
        "dec",
        "source",
        "text",
        "company",
        "coverage"
    ]
}